Clinical Trial

Testing Experimental Medication in Healthy Subjects

Study Description

A Single and Multiple Ascending Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of KP-1199

This is a Phase I, randomized, placebo and active-controlled, double blind, single and multiple ascending dose study in healthy adults to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of KP-1199

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - KP-1199

Single dose and Multiple ascending doses of KP-1199 oral capsules

Drug - Placebo oral capsule

Single dose and Multiple dose identical to active treatment but without KP-1199.

Drug - Oxycodone oral capsule

10 mg Oxycodone Capsules

Additional Information

Official Study Title

A Randomized, Placebo- and Active-Controlled, Double-Blind, Single and Multiple Ascending Dose Study in Healthy Adults to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of KP-1199

Clinical Trial ID

NCT03880487

ParticipAid ID

b4xwkb